GlassScriptPhysician profile
Scott A Sher
NPI 1962482679
$4,031.07
in general payments reported to CMS, 2019-2025
8 companies · $2,641 in 2025
The $2,641 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $471 · 2022: $185 · 2023: $401 · 2024: $333 · 2025: $2,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810 · Travel and Lodging: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.18 |
| Travel and Lodging | $1,564.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,673.17 | 2022-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $1,601.95 | 2021-2025 | Triclip, Mitraclip, Xience Skypoint |
| Abiomed | $405.08 | 2023-2025 | Impella |
| Atricure, INC. | $142.82 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Zimmer Biomet Holdings, INC. | $111.85 | 2023-2024 | Sternalock Blu System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.33 | 2022 | |
| Medtronic, INC. | $30.99 | 2024 | Abre |
| Amgen INC. | $20.88 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.